Quantinno Capital Management LP Acquires Shares of 71,271 Heartflow, Inc. $HTFL

Quantinno Capital Management LP acquired a new position in shares of Heartflow, Inc. (NASDAQ:HTFL) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 71,271 shares of the company’s stock, valued at approximately $1,734,000. Quantinno Capital Management LP owned 0.08% of Heartflow at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of HTFL. Caitong International Asset Management Co. Ltd acquired a new position in shares of Heartflow during the 4th quarter worth approximately $27,000. Russell Investments Group Ltd. bought a new position in shares of Heartflow in the fourth quarter worth $45,000. Legal & General Group Plc acquired a new position in Heartflow in the third quarter valued at about $59,000. Strs Ohio acquired a new stake in shares of Heartflow in the 4th quarter valued at $99,000. Finally, Bessemer Group Inc. acquired a new position in shares of Heartflow during the 1st quarter worth $126,000.

Analyst Ratings Changes

Several equities research analysts recently issued reports on HTFL shares. Freedom Capital raised shares of Heartflow to a “strong-buy” rating in a report on Tuesday, June 30th. Robert W. Baird began coverage on shares of Heartflow in a research report on Friday, July 31st. They issued an “outperform” rating and a $34.00 target price on the stock. Weiss Ratings raised shares of Heartflow from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday. William Blair initiated coverage on Heartflow in a research note on Monday, May 4th. They issued an “outperform” rating for the company. Finally, Wells Fargo & Company boosted their price objective on Heartflow from $35.00 to $37.00 and gave the stock an “overweight” rating in a research report on Friday, May 15th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Heartflow presently has a consensus rating of “Moderate Buy” and an average target price of $36.57.

Heartflow Stock Up 0.6%

Shares of Heartflow stock opened at $29.54 on Wednesday. The stock has a market cap of $2.55 billion and a price-to-earnings ratio of -9.50. Heartflow, Inc. has a twelve month low of $20.13 and a twelve month high of $41.22. The company’s fifty day moving average is $28.74 and its 200 day moving average is $27.73.

Heartflow (NASDAQ:HTFL) last released its quarterly earnings results on Thursday, May 14th. The company reported ($0.16) EPS for the quarter, beating analysts’ consensus estimates of ($0.24) by $0.08. The company had revenue of $52.59 million during the quarter. The business’s revenue for the quarter was up 41.3% on a year-over-year basis. As a group, equities analysts anticipate that Heartflow, Inc. will post -0.82 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, CEO John C.M. Farquhar sold 22,562 shares of the stock in a transaction on Friday, July 10th. The shares were sold at an average price of $27.75, for a total transaction of $626,095.50. Following the completion of the sale, the chief executive officer directly owned 435,373 shares in the company, valued at $12,081,600.75. This represents a 4.93% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Campbell Rogers sold 9,219 shares of Heartflow stock in a transaction on Monday, May 18th. The stock was sold at an average price of $28.34, for a total transaction of $261,266.46. Following the transaction, the insider directly owned 78,731 shares of the company’s stock, valued at $2,231,236.54. This represents a 10.48% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 93,243 shares of company stock valued at $2,891,879 in the last three months. Insiders own 7.70% of the company’s stock.

About Heartflow

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.